Literature DB >> 7622108

The major E6/E7 transcript of HPV-16 in exfoliated cells from cervical neoplasia patients.

T Fujii1, K Tsukazaki, K Kiguchi, K Kubushiro, M Yajima, S Nozawa.   

Abstract

HPV-16 is implicated in the development of progressive cervical neoplasia, and E6 and E7 proteins of this virus play important roles in its oncogenic activity. Reverse transcriptase-nested-polymerase chain reaction (RT-nested PCR) method was applied to detect the major transcript (E6*I/E7) from E6/E7 ORFs of HPV-16 in the exfoliated cervical and vaginal cells from cervical neoplasia patients. The incidence of the E6*I/E7 transcript was proportional to the class of cytologic diagnosis. Further analysis revealed that the incidence of the E6*I/E7 transcript in Pap smears of class I or II was 5/28 (18%) patients who had previously been diagnosed as having cervical neoplasia but was 1/37 (3%) patients who had never been diagnosed (P < 0.05). These findings suggest that some patients followed up for cervical neoplasia were infected with transcriptionally active HPVs even when their Pap smears were negative. In addition, the E6*I/E7 transcript could not be detected after surgical treatment in any of the cases that were able to be followed up. The E6*I/E7 transcript in the exfoliated cells may prove valuable for epidemiological studies of the pathogenesis of HPV infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7622108     DOI: 10.1006/gyno.1995.1213

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  5 in total

1.  Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening.

Authors:  Laurence Lamarcq; James Deeds; David Ginzinger; Jean Perry; Siddhartha Padmanabha; Karen Smith-McCune
Journal:  J Mol Diagn       Date:  2002-05       Impact factor: 5.568

2.  Detection of human papillomavirus type 16 early-gene transcription by reverse transcription-PCR is associated with abnormal cervical cytology.

Authors:  C Biswas; B Kell; C Mant; R J Jewers; J Cason; P Muir; K S Raju; J M Best
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

3.  Human papillomavirus 16 E6/E7 transcript and E2 gene status in patients with cervical neoplasia.

Authors:  Narayanan Sathish; Priya Abraham; Abraham Peedicayil; Gopalan Sridharan; Subhashini John; George Chandy
Journal:  Mol Diagn       Date:  2004

4.  Papanicolaou tests and molecular analyses using new fluid-based specimen collection technology in 3000 Japanese women.

Authors:  N Masumoto; T Fujii; M Ishikawa; M Mukai; M Saito; T Iwata; T Fukuchi; K Kubushiro; K Tsukazaki; S Nozawa
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

5.  p16(INK4a) immunohistochemistry is a promising biomarker to predict the outcome of low grade cervical intraepithelial neoplasia: comparison study with HPV genotyping.

Authors:  Sakiko Nishio; Takuma Fujii; Hiroshi Nishio; Kaori Kameyama; Miyuki Saito; Takashi Iwata; Kaneyuki Kubushiro; Daisuke Aoki
Journal:  J Gynecol Oncol       Date:  2013-07-04       Impact factor: 4.401

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.